Cargando…

Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications

[Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherica...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesabizadeh, Tina, Hicks, Evan, Medina Cruz, David, Bourdo, Shawn E., Watanabe, Fumiya, Bonney, Marvin, Nichols, John, Webster, Thomas J., Guisbiers, Grégory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280960/
https://www.ncbi.nlm.nih.gov/pubmed/35847343
http://dx.doi.org/10.1021/acsomega.2c02316
_version_ 1784746769335189504
author Hesabizadeh, Tina
Hicks, Evan
Medina Cruz, David
Bourdo, Shawn E.
Watanabe, Fumiya
Bonney, Marvin
Nichols, John
Webster, Thomas J.
Guisbiers, Grégory
author_facet Hesabizadeh, Tina
Hicks, Evan
Medina Cruz, David
Bourdo, Shawn E.
Watanabe, Fumiya
Bonney, Marvin
Nichols, John
Webster, Thomas J.
Guisbiers, Grégory
author_sort Hesabizadeh, Tina
collection PubMed
description [Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherical with a diameter of around 70 nm. The energy band gap of those nanoparticles was determined to be around 5.2 eV. Moreover, TeO(2) NPs displayed a dose-dependent antibacterial effect against antibiotic-resistant bacteria such as multidrug-resistant Escherichia coli (MDR E. coli) and methicillin-resistant Staphylococcus aureus (MR S. aureus). The “naked” nature of the nanoparticle surface helped to eradicate the antibiotic-resistant bacteria at a very low concentration, with IC50 values of ∼4.3 ± 0.9 and 3.7 ± 0.2 ppm for MDR E. coli and MR S. aureus, respectively, after just 8 h of culture. Further, the IC50 values of the naked TeO(2) NPs against melanoma (skin cancer) and healthy fibroblasts were 1.6 ± 0.7 and 5.5 ± 0.2 ppm, respectively, for up to 72 h. Finally, to understand these optimal antibacterial and anticancer properties of the TeO(2) NPs, the reactive oxygen species generated by the nanoparticles were measured. In summary, the present in vitro results demonstrate much promise for the presently prepared TeO(2) NPs and they should be studied for a wide range of safe antibacterial and anticancer applications.
format Online
Article
Text
id pubmed-9280960
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92809602022-07-15 Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications Hesabizadeh, Tina Hicks, Evan Medina Cruz, David Bourdo, Shawn E. Watanabe, Fumiya Bonney, Marvin Nichols, John Webster, Thomas J. Guisbiers, Grégory ACS Omega [Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherical with a diameter of around 70 nm. The energy band gap of those nanoparticles was determined to be around 5.2 eV. Moreover, TeO(2) NPs displayed a dose-dependent antibacterial effect against antibiotic-resistant bacteria such as multidrug-resistant Escherichia coli (MDR E. coli) and methicillin-resistant Staphylococcus aureus (MR S. aureus). The “naked” nature of the nanoparticle surface helped to eradicate the antibiotic-resistant bacteria at a very low concentration, with IC50 values of ∼4.3 ± 0.9 and 3.7 ± 0.2 ppm for MDR E. coli and MR S. aureus, respectively, after just 8 h of culture. Further, the IC50 values of the naked TeO(2) NPs against melanoma (skin cancer) and healthy fibroblasts were 1.6 ± 0.7 and 5.5 ± 0.2 ppm, respectively, for up to 72 h. Finally, to understand these optimal antibacterial and anticancer properties of the TeO(2) NPs, the reactive oxygen species generated by the nanoparticles were measured. In summary, the present in vitro results demonstrate much promise for the presently prepared TeO(2) NPs and they should be studied for a wide range of safe antibacterial and anticancer applications. American Chemical Society 2022-06-30 /pmc/articles/PMC9280960/ /pubmed/35847343 http://dx.doi.org/10.1021/acsomega.2c02316 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Hesabizadeh, Tina
Hicks, Evan
Medina Cruz, David
Bourdo, Shawn E.
Watanabe, Fumiya
Bonney, Marvin
Nichols, John
Webster, Thomas J.
Guisbiers, Grégory
Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title_full Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title_fullStr Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title_full_unstemmed Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title_short Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
title_sort synthesis of “naked” teo(2) nanoparticles for biomedical applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280960/
https://www.ncbi.nlm.nih.gov/pubmed/35847343
http://dx.doi.org/10.1021/acsomega.2c02316
work_keys_str_mv AT hesabizadehtina synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT hicksevan synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT medinacruzdavid synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT bourdoshawne synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT watanabefumiya synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT bonneymarvin synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT nicholsjohn synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT websterthomasj synthesisofnakedteo2nanoparticlesforbiomedicalapplications
AT guisbiersgregory synthesisofnakedteo2nanoparticlesforbiomedicalapplications